The following NICE published diagnostics assessments have been transferred to the static list.

Guidance is moved to the static list following consultation with registered stakeholders, when it is clear that there is no new research available that would have any material effect on the current guidance. Guidance on the static list may be transferred back to the active list for further assessment, if new evidence becomes available that is likely to have a material effect on the last guidance issued.

RefTitleDate IssuedReview decision
DG1 The EOS 2D/3D imaging system January 2017 Review decision
DG16 Fluorouracil chemotherapy: The My5‑FU assay for guiding dose adjustment February 2018 Review decision
DG15 Myocardial infarction (acute): early rule out using high-sensitivity troponin tests April 2018 Review decision
DG11 Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel October 2013 Review decision
DG9 EGFR‑TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer August 2013 Review decision
DG6 Depth of anaesthesia monitors – Bispectral Index (BIS), E-Entropy and Narcotrend-Compact M November 2012 Review decision
DG5 SonoVue (sulphur hexafluoride microbubbles) August 2012 Review decision
DG3 New generation cardiac CT scanners   January 2012 Review decision